DEI/Trial Diversification
Breaking down how to enhance clinical trial diversity and inclusion among underserved and underrepresented populations through strategic and intentional patient-centered approaches.
EP. 2: Implementing Diversity, Equity, and Inclusion in Drug Development
February 13th 2025Jennifer Kim, PhD, assistant research professor, Tufts School of Medicine, Tufts Center for the Study of Drug Development, discusses barriers to participation for underrepresented populations in clinical trials and how Tufts is conducting research to better understand their nature.
